Literature DB >> 11792174

Development of a conjugate of (99m)Tc-EC with aminomethylenediphosphonate in the search for a bone tracer with fast clearance from soft tissue.

Kristin Verbeke1, Jef Rozenski, Bernard Cleynhens, Hubert Vanbilloen, Tjibbe de Groot, Nancy Weyns, Guy Bormans, Alfons Verbruggen.   

Abstract

For the currently used (99m)Tc-labeled diphosphonates such as (99m)Tc-MDP and (99m)Tc-HDP, the required interval of 2.5 to 3 h between injection and the scintigraphic bone imaging is an inconvenience. The present study was set up in an attempt to develop a technetium-99m-labeled diphosphonate with efficient bone uptake and more rapid clearance from blood and soft tissue by renal extraction and excretion so that it would be possible to start imaging as early as 1 h after injection. A conjugate of the new renal tracer agent (99m)Tc-ethylene dicysteine ((99m)Tc-L,L-EC), covalently bound via one of its carboxylates with aminomethylenediphosphonic acid (AMDP), was synthesized in seven steps. EC-AMDP could be labeled easily and efficiently with (99m)Tc at pH > or = 12 and room temperature. Analysis using ion pair reversed phase high performance liquid chromatography showed the formation of a mixture of two main compounds with reproducible relative ratios, which were stable as a function of time. In a baboon, the scintigraphic images obtained with the new agent showed good quality bone scans, with clear visualization of the skeleton and low soft tissue activity at respectively 1 and 2 h after injection.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11792174     DOI: 10.1021/bc0001600

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  6 in total

1.  Advances in drug design of radiometal-based imaging agents for bone disorders.

Authors:  Kazuma Ogawa; Hideo Saji
Journal:  Int J Mol Imaging       Date:  2011-12-15

2.  A new bisphosphonate-containing (99m)Tc(I) tricarbonyl complex potentially useful as bone-seeking agent: synthesis and biological evaluation.

Authors:  Elisa Palma; Bruno L Oliveira; João D G Correia; Lurdes Gano; Leonor Maria; Isabel C Santos; Isabel Santos
Journal:  J Biol Inorg Chem       Date:  2007-03-02       Impact factor: 3.862

Review 3.  Well-designed bone-seeking radiolabeled compounds for diagnosis and therapy of bone metastases.

Authors:  Kazuma Ogawa; Atsushi Ishizaki
Journal:  Biomed Res Int       Date:  2015-05-14       Impact factor: 3.411

4.  Development of novel radiogallium-labeled bone imaging agents using oligo-aspartic acid peptides as carriers.

Authors:  Kazuma Ogawa; Atsushi Ishizaki; Kenichiro Takai; Yoji Kitamura; Tatsuto Kiwada; Kazuhiro Shiba; Akira Odani
Journal:  PLoS One       Date:  2013-12-31       Impact factor: 3.240

5.  Synthesis and biological evaluation of novel (99m)Tc-labelled bisphosphonates as superior bone imaging agents.

Authors:  Ling Qiu; Wen Cheng; Jianguo Lin; Shineng Luo; Li Xue; Jing Pan
Journal:  Molecules       Date:  2011-07-25       Impact factor: 4.411

Review 6.  Bisphosphonate conjugation for bone specific drug targeting.

Authors:  Kristen B Farrell; Alexander Karpeisky; Douglas H Thamm; Shawn Zinnen
Journal:  Bone Rep       Date:  2018-07-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.